Switch theme
Sign up to access all valuation multiples
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company’s revenues arise from operations in Argentina.
2022
52
LTM Revenue $6.1M
LTM EBITDA n/a
$47.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Moolec Science has a last 12-month revenue of $6.1M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Moolec Science achieved revenue of $5.6M and an EBITDA of -$6.2M.
Moolec Science expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Moolec Science valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $0.9M | $5.6M | XXX | XXX | XXX |
| Gross Profit | n/a | -$0.1M | XXX | XXX | XXX |
| Gross Margin | NaN% | -3% | XXX | XXX | XXX |
| EBITDA | -$51.7M | -$6.2M | XXX | XXX | XXX |
| EBITDA Margin | -5717% | -110% | XXX | XXX | XXX |
| Net Profit | -$4.5M | -$51.8M | XXX | XXX | XXX |
| Net Margin | -500% | -921% | XXX | XXX | XXX |
| Net Debt | n/a | $0.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Moolec Science's stock price is $1.
Moolec Science has current market cap of $28.8M, and EV of $47.3M.
See Moolec Science trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $47.3M | $28.8M | XXX | XXX | XXX | XXX | $-0.19 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Moolec Science has market cap of $28.8M and EV of $47.3M.
Moolec Science's trades at 7.7x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Moolec Science's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Moolec Science and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $47.3M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMoolec Science's NTM/LTM revenue growth is -100%
Moolec Science's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Moolec Science's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Moolec Science's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Moolec Science and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 522% | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | -88% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 11% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 116% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 32% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 169% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Oatly | XXX | XXX | XXX | XXX | XXX | XXX |
| Beyond Meat | XXX | XXX | XXX | XXX | XXX | XXX |
| Oatly | XXX | XXX | XXX | XXX | XXX | XXX |
| Ingredion | XXX | XXX | XXX | XXX | XXX | XXX |
| Local Bounti | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Moolec Science acquired XXX companies to date.
Last acquisition by Moolec Science was XXXXXXXX, XXXXX XXXXX XXXXXX . Moolec Science acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Moolec Science founded? | Moolec Science was founded in 2022. |
| Where is Moolec Science headquartered? | Moolec Science is headquartered in United States of America. |
| How many employees does Moolec Science have? | As of today, Moolec Science has 52 employees. |
| Who is the CEO of Moolec Science? | Moolec Science's CEO is Mr. Gaston Paladini. |
| Is Moolec Science publicy listed? | Yes, Moolec Science is a public company listed on NAS. |
| What is the stock symbol of Moolec Science? | Moolec Science trades under MLEC ticker. |
| When did Moolec Science go public? | Moolec Science went public in 2023. |
| Who are competitors of Moolec Science? | Similar companies to Moolec Science include e.g. Oatly, Beyond Meat, Oatly, Ingredion. |
| What is the current market cap of Moolec Science? | Moolec Science's current market cap is $28.8M |
| What is the current revenue of Moolec Science? | Moolec Science's last 12-month revenue is $6.1M. |
| What is the current EV/Revenue multiple of Moolec Science? | Current revenue multiple of Moolec Science is 7.7x. |
| What is the current revenue growth of Moolec Science? | Moolec Science revenue growth between 2023 and 2024 was 522%. |
| Is Moolec Science profitable? | Yes, Moolec Science is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
